Sabra Health Care REIT (SBRA) Given a $22.00 Price Target at SunTrust Banks

Sabra Health Care REIT (NASDAQ:SBRA) received a $22.00 price target from SunTrust Banks in a research note issued to investors on Monday. The brokerage currently has a “buy” rating on the real estate investment trust’s stock. SunTrust Banks’ price target would suggest a potential upside of 23.87% from the company’s current price.

Several other research firms also recently weighed in on SBRA. Jefferies Group reiterated a “buy” rating and set a $24.00 target price (down from $25.00) on shares of Sabra Health Care REIT in a research report on Wednesday, September 27th. Capital One Financial assumed coverage on Sabra Health Care REIT in a research report on Monday, September 25th. They set an “equal weight” rating and a $24.00 target price on the stock. ValuEngine upgraded Sabra Health Care REIT from a “hold” rating to a “buy” rating in a research report on Monday, October 2nd. Mizuho restated a “hold” rating and issued a $23.00 price objective on shares of Sabra Health Care REIT in a report on Wednesday, October 4th. Finally, Cantor Fitzgerald restated a “buy” rating and issued a $30.00 price objective on shares of Sabra Health Care REIT in a report on Thursday, September 28th. Three research analysts have rated the stock with a sell rating, seven have given a hold rating and three have given a buy rating to the company’s stock. Sabra Health Care REIT currently has a consensus rating of “Hold” and a consensus price target of $24.10.

Sabra Health Care REIT (NASDAQ:SBRA) traded down $0.01 during midday trading on Monday, reaching $17.76. The company had a trading volume of 1,404,500 shares, compared to its average volume of 1,511,239. Sabra Health Care REIT has a 1 year low of $17.61 and a 1 year high of $29.10. The stock has a market capitalization of $3,180.00, a P/E ratio of 22.77, a PEG ratio of 2.42 and a beta of 0.93. The company has a debt-to-equity ratio of 0.89, a current ratio of 1.66 and a quick ratio of 1.66.

Sabra Health Care REIT (NASDAQ:SBRA) last released its earnings results on Wednesday, November 1st. The real estate investment trust reported $0.11 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.68 by ($0.57). Sabra Health Care REIT had a return on equity of 4.86% and a net margin of 25.79%. sell-side analysts predict that Sabra Health Care REIT will post 2.47 EPS for the current fiscal year.

In other news, Director Milton J. Walters sold 4,615 shares of the firm’s stock in a transaction dated Thursday, November 30th. The stock was sold at an average price of $19.18, for a total value of $88,515.70. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Company insiders own 2.60% of the company’s stock.

Several large investors have recently made changes to their positions in the stock. Vanguard Group Inc. raised its holdings in shares of Sabra Health Care REIT by 6.4% during the 2nd quarter. Vanguard Group Inc. now owns 13,229,559 shares of the real estate investment trust’s stock valued at $318,832,000 after buying an additional 797,491 shares during the period. BlackRock Inc. raised its holdings in shares of Sabra Health Care REIT by 3.0% during the 2nd quarter. BlackRock Inc. now owns 9,570,432 shares of the real estate investment trust’s stock valued at $230,649,000 after buying an additional 277,421 shares during the period. Bank of New York Mellon Corp raised its holdings in shares of Sabra Health Care REIT by 294.2% during the 3rd quarter. Bank of New York Mellon Corp now owns 4,721,303 shares of the real estate investment trust’s stock valued at $103,586,000 after buying an additional 3,523,631 shares during the period. APG Asset Management US Inc. raised its holdings in shares of Sabra Health Care REIT by 11.1% during the 4th quarter. APG Asset Management US Inc. now owns 3,193,000 shares of the real estate investment trust’s stock valued at $59,933,000 after buying an additional 319,000 shares during the period. Finally, Dimensional Fund Advisors LP raised its holdings in shares of Sabra Health Care REIT by 151.8% during the 3rd quarter. Dimensional Fund Advisors LP now owns 2,405,450 shares of the real estate investment trust’s stock valued at $52,774,000 after buying an additional 1,450,287 shares during the period. Institutional investors and hedge funds own 85.01% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This report was first published by Sports Perspectives and is owned by of Sports Perspectives. If you are viewing this report on another website, it was illegally stolen and republished in violation of U.S. and international copyright and trademark laws. The legal version of this report can be accessed at https://sportsperspectives.com/2018/01/22/sabra-health-care-reit-sbra-given-a-22-00-price-target-at-suntrust-banks.html.

Sabra Health Care REIT Company Profile

Sabra Health Care REIT, Inc is a real estate investment trust. The Company, through its subsidiaries, owns and invests in real estate serving the healthcare industry. The Company’s segment includes investments in healthcare-related real estate properties. The Company’s primary business consists of acquiring, financing and owning real estate property to be leased to third-party tenants in the healthcare sector.

Analyst Recommendations for Sabra Health Care REIT (NASDAQ:SBRA)

Receive News & Ratings for Sabra Health Care REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Health Care REIT and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply